期刊文献+

Smad3基因RNAi慢病毒载体的构建与鉴定 被引量:3

Construction and identification of lentiviral vector encoding shRNA against Smad3
下载PDF
导出
摘要 目的构建Smad3基因RNAi慢病毒载体。方法针对已经筛选确定的Smad3基因RNAi有效靶序列,合成靶序列的Oligo DNA,退火形成双链DNA,与经AgeⅠ和EcoRⅠ双酶切后的pGCSIL-GFP载体连接产生GC-shSmad3慢病毒载体,PCR筛选阳性克隆,测序鉴定。用GC-shSmad3、pHelper 1.0载体和pHelper 2.0载体共转染包装细胞293T细胞,包装产生慢病毒,以293T细胞GFP蛋白的表达水平测定病毒滴度。结果PCR和测序证实,构建出了Smad3 shRNA的慢病毒载体GC-shSmad3。包装慢病毒,浓缩病毒悬液的滴度为3×108TU/ml。结论成功构建Smad3基因RNAi慢病毒载体。 Objective To construct a lentiviral vector expressing small-hairpin RNA (shRNA) targeting Smad3 gene. Methods The targeting sequence of Smad3 gene which can be effectively silenced in RNA inference was confirmed in our previous study. The cDNA containing both sense and antisense Oligo DNA fragments of the targeting sequence was designed, synthesized and cloned into the pGCSIL-GFP vector. The obtained lentiviral vector containing Smad3 shRNA was confirmed by PCR and sequencing. 293T cells were cotransfected with lentiviral vector GC-shSmad3, pHelper 1.0 and pHelper 2.0. The titer of virus was tested according to the expression level of GFP. Results PCR and DNA sequencing demonstrated that the constructed lentivirus vec- tor GC-shSmad3 produced Smad3 shRNA. The titer of concentrated virus was 3 ×10^8TU/ml. Conclusion The lentivirus RNAi vector targeting Smad3 is constructed successfully.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第8期701-702,共2页 Journal of Third Military Medical University
基金 国家自然科学基金(30500539)~~
关键词 RNA干扰 SMAD3 慢病毒 RNA interference Smad3 lentivirus
  • 相关文献

参考文献2

二级参考文献84

  • 1[1]Uitto J,Kouba D.Cytokine modulation of extracellular matrix gene expression:relevance to fibrotic skin diseases.J Dermatol Sci 2000; 24 Suppl 1:S60-S69
  • 2[2]Verrecchia F,Mauviel A.TGF-beta and TNF-alpha:antagonis tic cytokines controlling type I collagen gene expression.Cell Signal 2004; 16:873-880
  • 3[3]Verrecchia F,Mauviel A.Control of connective tissue gene expression by TGF beta:role of Smad proteins in fibrosis.Curr Rheumatol Rep 2002; 4:143-149
  • 4[4]Verrecchia F,Mauviel A.Transforming growth factor-beta signaling through the Smad pathway:role in extracellular matrix gene expression and regulation.J Invest Dermatol 2002; 118:211-215
  • 5[5]LeRoy EC,Trojanowska MI,Smith EA.Cytokines and human fibrosis.Eur Cytokine Netw 1990; 1:215-219
  • 6[6]Schiller M,Javelaud D,Mauviel A.TGF-beta-induced SMAD signaling and gene regulation:consequences for extracellular matrix remodeling and wound healing.J Dermatol Sri 2004; 35:83-92
  • 7[7]Grotendorst GR.Connective tissue growth factor:a mediator of TGF-beta action on fibroblasts.Cytokine Growth Factor Rev 1997; 8:171-179
  • 8[8]Leask A,Denton CP,Abraham DJ.Insights into the molecular mechanism of chronic fibrosis:the role of connective tissue growth factor in scleroderma.J Invest Dermatol 2004; 122:1-6
  • 9[9]Feng XH,Derynck R.Specificity and versatility in tgf-beta signaling through Smads.Annu Rev Cell Dev Biol 2005; 21:659-693
  • 10[10]Roberts AB.Molecular and cell biology of TGF-beta.Miner Electrolyte Metab 1998; 24:111-119

共引文献161

同被引文献23

  • 1王玮,朱焕章,薛京伦.RNA干涉在基因治疗中的应用[J].生物化学与生物物理进展,2004,31(7):590-595. 被引量:6
  • 2李天伯,胡洋,王以光,夏焕章.mMR-1基因的克隆和在毕赤酵母中分泌表达[J].生物工程学报,2005,21(1):25-29. 被引量:3
  • 3康慧聪,唐洲平,朱遂强.RNAi及其基因治疗研究进展[J].卒中与神经疾病,2005,12(3):191-192. 被引量:5
  • 4徐菲菲,刘秀华,王彦珍,李天伯,王以光.肌原纤维调节因子-1在心肌肥大中的作用研究[J].中国病理生理杂志,2006,22(3):443-447. 被引量:6
  • 5陈煜,谢小芳.RNAi的作用机制及抗病毒研究进展[J].世界华人消化杂志,2006,14(21):2123-2129. 被引量:11
  • 6Song C, Hu C D, Masago M, et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras [ J]. J Biol Chem, 2001, 276(4): 2752-2757.
  • 7Lopez I, Mark E C, Ding J, et al. A novel bifunetional phospholipase C that is regulated by Galpha 12 and stimulates the Ras/Mitogenactivated protein kinase pathway [ J ]. J Biol Chem, 2001, 276 (4) : 2758 - 2765.
  • 8Jin T G, Satoh T, Liao Y, et al. Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling [J]. J Biol Chem, 2001, 276(32): 30301 -30307.
  • 9Song C, Satoh T, Edamatsu H, et al. Differential roles of Ras and Rapl in growth factor-dependent activation of phospholipase C epsilon [J]. Oncogene, 2002, 21(53): 8105-8113.
  • 10Siolas D, Lemer C, Burchard J, et al. Synthetic shRNAs as potent RNAi triggers[J]. Nat Biotechnol, 2005, 23(2): 227-231.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部